Department of Cardiology, Rangueil Toulouse University Hospital, University Paul Sabatier, Toulouse, France.
Division of Cardiology, University of Verona, Italy.
Am J Cardiol. 2021 Mar 15;143:29-36. doi: 10.1016/j.amjcard.2020.12.040. Epub 2021 Jan 5.
Data regarding the potential influence of gender on outcomes of rotational atherectomy (RA) percutaneous coronary intervention (PCI) are scarce and conflicting. Using the Euro4C registry, an international prospective multicentric registry of RA PCI, we evaluated the influence of gender on clinical outcomes of RA PCI. Between October 2016 and July 2018, 966 patients were included. In them, 267 (27.6%) were females. Female patients were older than males (77.7 years old ± 9.8 vs 73.3 ± 9.5 years old respectively, p < 0.001) had a poorer renal function (43,1% of females had a GFR < 60 ml/min:1.73m² vs 30.4% of males, p < 0.001) and were more frequently admitted for an acute coronary syndrome (32.2% vs 22.3% p = 0.002). During RA procedure, women were less likely to be treated by radial approach (65.0% vs 74.4%, p = 0.004). In-hospital major adverse cardiac event rate-defined as cardiovascular death, myocardial infarction, stroke/transient ischemic attack, target lesion revascularization, and coronary artery bypass grafting surgery-was higher in the female group (7.1% vs 3.7%, p = 0.043). However, coronary perforation, dissection, slow/low flow and tamponade did not significantly differ in gender, neither did cardiovascular medications at discharge. At 1 year follow-up, rate of major adverse cardiac event was 18.4% in the female group vs 11.2% in the male group (adjusted Hazard Ratio 1.82 [1.24 to 2.67], p = 0.002). No significant bleeding differences were observed in gender, neither in hospital, nor during follow-up. In conclusion women had worse clinical outcomes following RA PCI during hospitalization and at 1 year follow-up than did men.
关于性别对旋磨经皮冠状动脉介入治疗(RA-PCI)结果影响的数据很少且存在争议。本研究使用国际多中心前瞻性 RA-PCI 注册研究 Euro4C 注册表,评估了性别对 RA-PCI 临床结局的影响。2016 年 10 月至 2018 年 7 月,共纳入 966 例患者,其中 267 例(27.6%)为女性。与男性相比,女性患者年龄更大(77.7 岁±9.8 岁 vs 73.3 岁±9.5 岁,p<0.001),肾功能更差(43.1%的女性肾小球滤过率(GFR)<60 ml/min:1.73m² vs 30.4%的男性,p<0.001),更常因急性冠状动脉综合征入院(32.2% vs 22.3%,p=0.002)。在 RA 手术过程中,女性更倾向于接受桡动脉入路治疗(65.0% vs 74.4%,p=0.004)。女性患者住院期间主要不良心脏事件发生率(定义为心血管死亡、心肌梗死、卒中和短暂性脑缺血发作、靶病变血运重建和冠状动脉旁路移植术)较高(7.1% vs 3.7%,p=0.043)。然而,性别之间的冠状动脉穿孔、夹层、慢血流/低血流和心脏压塞并无显著差异,出院时的心血管药物也无显著差异。在 1 年随访期间,女性组的主要不良心脏事件发生率为 18.4%,男性组为 11.2%(调整后的危害比为 1.82[1.24 至 2.67],p=0.002)。性别之间在住院期间和随访期间的出血发生率无显著差异。总之,女性在 RA-PCI 住院期间和 1 年随访期间的临床结局比男性更差。